Abstract
Background The study was designed to estimate daily salt intake, its discretionary use in healthy individuals and to validate three common methods for salt estimation in Pakistani population.
Methods Information on demography and discretionary salt use was collected healthy adults (>18 years) along with a blood sample, spot urine sample and 24 hours urine samples. Sodium, chloride, potassium levels and serum creatinine were measured using standard methods. For daily salt estimation, three common methods i.e. INTERSALT, Tanaka and Kawasaki were validated for their applicability in local settings.
Results Overall 24 h sodium excretion was 158 mmol/l indicating intake of 8.64 (±4.43) grams salt per day which was significantly associated with male gender (p. <0.004) and adding salt during cooking (p. <0.0001). Most (73%) of the participants know about hazardous effects of high salt intake, however, only 25% consider important to lower salt intake. Although, there is insignificant difference (p. 0.09) between measured and estimated 24 hour urine however none of three methods i.e. INTERSALT(bias: -19.64; CCC -0.79), Tanaka(bias: 167.35; CCC -0.37) and Kawasaki (bias: -42.49, CCC -0.79) showed any agreement between measured and estimated 24 hour sodium.
Conclusion Daily intake of salt was high than recommended by the WHO. Findings showed that none of the three methods could be used for estimating daily intake of salt in local settings of Pakistan.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was financially supported by the Pakistan Health Research Council [15/2016/RDC/Head Office]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Bioethics Committee of Pakistan Health Research Committee provided ethical clearance.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Ph.No. 0092-51-9207368, Email. arif289{at}gmail.com
Ph.No. 0092-51-9224327, Email. ibrarpmrc{at}gmail.com
Email address ansar{at}qau.edu.pk
Ph.No. 0092-51-9207386. Email address: tayyabarahat{at}gmail.com
Data Availability
The data will be available.